New Delhi The central government has directed states and Union Territories to ensure that hospitals and clinics prominently display the charges for their healthcare services, aiming to improve transparency in treatment costs and protect patients’ interests. Under the directive, healthcare establishments must display their fee schedules in both the relevant local language and English. Separately, the Supreme Court has raised questions about the need for broader regulation of medicine prices, while the National Medical Commission (NMC) has instructed medical colleges to establish patient safety committees in their affiliated hospitals.
These three developments address different but important aspects of healthcare, including treatment affordability, informed decision-making and patient protection. Their common objective is to improve access to information and strengthen accountability within the healthcare system.
Hospitals and Clinics Must Display Service Charges
The central government has urged all states and Union Territories to strictly implement the provisions of the Clinical Establishments Act. Union Health Secretary Punya Salila Srivastava has written to the chief secretaries of states and Union Territories, emphasising the need for clear disclosure of healthcare service charges.
The communication states that patients and their families should be able to easily see and understand the fees charged for different medical services. Hospitals and clinics must display their rate lists prominently so that patients can assess the likely cost of treatment before making decisions.
Displaying charges only in the local language will not be sufficient. The fee schedule must also be available in English to make the information accessible to patients from different linguistic backgrounds.
According to the government’s approach, transparent pricing can help patients estimate their potential medical expenses in advance, compare available treatment options, make informed healthcare decisions and plan their finances more effectively.
Law Enacted in 2010, Implementation Remains a Challenge
The Clinical Establishments Act was passed in 2010 and notified in 2012. The legislation provides a framework for the registration and regulation of clinical establishments.
However, the provisions of the law have not been fully implemented in several states, according to the information provided in the report. The Centre has now called on states and Union Territories to ensure more effective compliance.
Clear display of service charges is expected to help patients understand the cost of hospital services and reduce uncertainty about treatment expenses.
Transparency in Treatment Packages for Foreign Patients
The central government has also emphasised the need for transparency in the prices charged to foreign patients seeking medical treatment in India.
States and Union Territories have been asked to encourage hospitals, wherever applicable, to prominently display package rates offered to foreign patients travelling to India on medical or AYUSH visas.
The objective is to ensure that international patients have access to information about the likely cost of treatment before making arrangements for their medical visits. Clear disclosure of package rates can help them plan their treatment and estimate expenses in advance.
Supreme Court Questions Why Drug Price Controls Are Limited
In a separate development, the Supreme Court has expressed concern over substantial profit margins in the medicines and medical devices market. The court questioned the Centre over its approach to regulating trade margins, asking why the government should not consider fixing prices across a wider range of medicines instead of restricting such controls to certain cancer drugs.
A bench comprising Justice Vikram Nath and Justice Sandeep Mehta emphasised the need to examine the scope of drug price regulation. The court asked the central government to undertake a comprehensive review of medicine prices.
During the hearing, the bench took note of the Centre’s decision to impose a 30% trade margin cap on certain cancer medicines. It questioned why such a measure should remain limited to cancer drugs and whether the approach to price regulation required a broader review.
The observations have brought renewed attention to medicine pricing, trade margins and the affordability of healthcare. However, the court’s remarks do not, by themselves, amount to a final decision imposing a uniform trade margin cap on all medicines. Any broader regulatory changes would depend on subsequent government action and the legal proceedings.
NMC Directs Medical Colleges to Establish Patient Safety Committees
In another measure aimed at strengthening patient protection, the National Medical Commission has directed all medical colleges to establish Patient Safety Committees in their affiliated hospitals.
According to the instructions, the committee will be chaired by the institution’s director and will include specialist doctors representing the hospital’s major departments. It will monitor matters relating to the welfare, care and safety of admitted patients.
The initiative follows directions from the Director General of Health Services. Medical colleges must constitute the committees and inform the NMC once the process has been completed.
Hospitals have also been instructed to appoint a nodal officer to facilitate the timely resolution of matters concerning patient safety and care. The officer will play a role in coordinating the handling of such cases and helping expedite the resolution process.
Focus on Treatment Costs and Patient Protection
The directions on hospital fee disclosure, the Supreme Court’s questions on medicine pricing and the NMC’s instructions on patient safety committees address three distinct areas of healthcare regulation.
While transparent fee schedules can help patients understand treatment costs, the debate over medicine prices concerns the broader regulation of medical expenses. Patient safety committees, meanwhile, are intended to strengthen monitoring of the care and protection provided to people admitted to hospitals.
The actual impact of these measures will depend on effective implementation, compliance by healthcare establishments and the enforcement of applicable regulatory requirements.
